News
-
- Research and Development
-
- Investor Relations
-
Nippon Shokubai Signs Location Agreement for Establishment of New IONEL™ Plant
-
- Investor Relations
-
- Investor Relations
-
Nippon Shokubai to Exhibit at European Coatings Show (ECS) 2025
-
- Investor Relations
-
- Investor Relations
-
- Investor Relations
-
- Investor Relations
-
- Research and Development
3D Cell Culture Vessel “MicoCell™” First Application in Regenerative Medicine
-
- Management and Business
Nippon Shokubai Announces Shares Acquisition of Lilac pharma (to Make It a Subsidiary)
-
- Investor Relations
-
- Investor Relations
- Sustainability
Nippon Shokubai Published “TechnoAmenity Report 2024,” and “Financial Report 2024.”
-
- Investor Relations
-
- Investor Relations
Notice Regarding Acquisition of Shares of Emulsion Technology Co., Ltd. (to Make It a Subsidiary)
-
- Investor Relations
-
- Investor Relations
-
- Investor Relations
Notice Regarding Revisions to Dividend of Surplus (Interim Dividend) and Year-end Dividend Forecast